0001179110-15-001100.txt : 20150121
0001179110-15-001100.hdr.sgml : 20150121
20150121202945
ACCESSION NUMBER: 0001179110-15-001100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150116
FILED AS OF DATE: 20150121
DATE AS OF CHANGE: 20150121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KYTHERA BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001436304
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 818-587-4500
MAIL ADDRESS:
STREET 1: 27200 WEST AGOURA ROAD
STREET 2: SUITE 200
CITY: CALABASAS
STATE: CA
ZIP: 91301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Samuels Camille D
CENTRAL INDEX KEY: 0001354034
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35663
FILM NUMBER: 15540035
MAIL ADDRESS:
STREET 1: 2463 JACKSON ST.
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94115
4
1
edgar.xml
FORM 4 -
X0306
4
2015-01-16
0
0001436304
KYTHERA BIOPHARMACEUTICALS INC
KYTH
0001354034
Samuels Camille D
C/O KYTHERA BIOPHARMACEUTICALS, INC.
30930 RUSSELL RANCH ROAD, SUITE 300
WESTLAKE VILLAGE
CA
91362
1
0
0
0
Common Stock
2015-01-16
4
S
0
100
36.22
D
15835
D
Common Stock
2015-01-16
4
S
0
150
37.02
D
15685
D
The sales reported in this Form 4 were effected pursuant to the Reporting Person's 10b5-1 plan which expires December 31, 2015.
Reflects the pro rata distribution of an aggregate of 15,935 shares from Versant Ventures II, LLC to the Reporting Person as follows: 4,519 shares on October 3, 2013, 4,965 shares on October 15, 2013, and 6,451 shares on March 4, 2014. The Reporting Person no longer has beneficial ownership of shares previously reported as indirectly held by Versant Venture Capital II, L.P., Versant Side Fund II, L.P., Versant Affiliates Fund II-A, L.P. and Versant Venture Management LLC.
Keith Klein, as Attorney-in-Fact for Camille Samuels
2015-01-21